Li et al. established an AD model by injecting D-galactose and Aβ1–42 and found Rgl affects tau protein phosphorylation by inhibiting the activity of CDK5 in hippocampal neurons [21]. The gene discussed is MAPT; the disease is Alzheimer disease.